Dovato 50-300 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FEZDV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $102,122
Award facts
- Contract value 100% obligated
- $102,121.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $102,121.94 to AmerisourceBergen Drug Corp for the supply of Dovato 50-300 mg tablets in quantities of 30 units. This firm fixed price, non-set-aside contract was awarded on August 1, 2025, with an ultimate completion date of August 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
This award underscores AmerisourceBergen's critical role as a pharmaceutical prime vendor for the Defense Health Agency and military healthcare systems. Dovato, an antiretroviral medication used in HIV treatment, falls within the broad spectrum of pharmaceutical products the company supplies through its DLA contract portfolio, which encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains. The short completion timeline reflects the routine nature of delivery orders executed under the larger IDC framework, enabling DLA to efficiently source pharmaceutical products to support military healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DB25FEZDV?
SPE2DB25FEZDV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 1, 2025.
How much is contract SPE2DB25FEZDV worth?
The government has obligated $102,122 on SPE2DB25FEZDV.
Is contract SPE2DB25FEZDV an order under another contract?
Yes. SPE2DB25FEZDV is a delivery order under SPE2DB24D1021, an indefinite delivery contract.
Was contract SPE2DB25FEZDV competed?
The extent of competition for SPE2DB25FEZDV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award